United States
Germany
Japan
United Kingdom
China
Antibodies
IL17 (IL17A) mouse monoclonal antibody, clone 403D10.01
| Applications | ELISA |
| Reactivities | Canine, Human |
CNY 6,798.00
5周
STAT3 pTyr705 (incl. pos. control) mouse monoclonal antibody, clone 9E12, Biotin
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Canine, Human, Mouse |
CNY 5,973.00
5周
beta Catenin (CTNNB1) (exon 3) (incl. pos. control) mouse monoclonal antibody, clone 9G2, Biotin
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Canine, Human, Mouse |
CNY 5,973.00
5周
Phosphotyrosine (incl. pos. control) mouse monoclonal antibody, clone 2C8, Biotin
| Applications | ELISA, IP, WB |
| Reactivities | Canine, Human, Mouse, Rat |
CNY 6,798.00
5周
EGFR pTyr1173 (incl. pos. control) mouse monoclonal antibody, clone 9H2, Biotin
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Canine, Human, Mouse |
活动过滤器
优化搜索结果
Target Symbol
Clonalities
Assay Types
Pathways
- Adherens junction (4)
- Bladder cancer (4)
- Endometrial cancer (4)
- ErbB signaling pathway (4)
- Focal adhesion (4)
- Non-small cell lung cancer (4)
- Pancreatic cancer (4)
- Pathways in cancer (4)
- Prostate cancer (4)
- Toll-like receptor signaling pathway (3)
- Acute myeloid leukemia (2)
- Alzheimer's disease (2)
- Axon guidance (2)
- B cell receptor signaling pathway (2)
- Calcium signaling pathway (2)
- Chemokine signaling pathway (2)
- Chronic myeloid leukemia (2)
- Colorectal cancer (2)
- Dorso-ventral axis formation (2)
- Fc epsilon RI signaling pathway (2)
- Fc gamma R-mediated phagocytosis (2)
- Gap junction (2)
- Glioma (2)
- GnRH signaling pathway (2)
- Insulin signaling pathway (2)
- Long-term depression (2)
- Long-term potentiation (2)
- MAPK signaling pathway (2)
- Melanogenesis (2)
- Melanoma (2)
- NOD-like receptor signaling pathway (2)
- Natural killer cell mediated cytotoxicity (2)
- Neurotrophin signaling pathway (2)
- Oocyte meiosis (2)
- Prion diseases (2)
- Progesterone-mediated oocyte maturation (2)
- Regulation of actin cytoskeleton (2)
- Renal cell carcinoma (2)
- T cell receptor signaling pathway (2)
- TGF-beta signaling pathway (2)
- Thyroid cancer (2)
- Type II diabetes mellitus (2)
- VEGF signaling pathway (2)
- Vascular smooth muscle contraction (2)
- mTOR signaling pathway (2)
- Pathogenic Escherichia coli infection (1)
